During the past decade, major advances have been made in the accurate diagnosis of
severe cutaneous adverse reactions (SCARs) to drugs, management of their manifestations …

Severe cutaneous adverse reactions to medications (SCARs) are dose-dependent
manifestations of hypersensitivity phenotypes. Drug reaction with eosinophilia and systemic …

Abstract Purpose of Study Immune-mediated adverse drug reactions occur commonly in
clinical practice and include mild, self-limited cutaneous eruptions, IgE-mediated …

Epidemiologic investigations of cutaneous adverse drug reactions (cADR) are important to
evaluate their impact in dermatology and health care in general as well as their burden for …

Cutaneous adverse drug reactions are frequent, affecting 2–3% of hospitalized patients and
in one twentieth of them are potentially life-threatening. Almost any pharmacologic agent …

Adverse drug reactions involving the skin are commonly known as drug eruptions. Severe
drug eruption may cause severe cutaneous adverse drug reactions (SCARs), which are …

Severe skin adverse drug reactions can result in death, but the rate of such events is
fortunately low. The incidences of Stevens-Johnson syndrome and toxic epidermal …

Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe
cutaneous adverse reactions (SCAR) related to a variety of medications. They have a …

Most immune-mediated adverse drug reactions (IM-ADRs) involve the skin, and many have
additional systemic features. Severe cutaneous adverse drug reactions (SCARs) are an …

The clinical manifestations of drug eruptions can range from mild maculopapular exanthema
to severe cutaneous adverse drug reactions (SCAR), including drug‐induced …